Trials / Completed
CompletedNCT00210015
A Study in Subjects With Perennial Allergic Rhinitis
A Multi-Center, Randomized, Parallel-Group, Double-Blind, Efficacy and Safety Study of INS37217 Nasal Spray Versus Placebo in Subjects With Perennial Allergic Rhinitis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 630 (planned)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- —
- Age
- —
- Healthy volunteers
- —
Summary
The purpose of this study was to determine the efficacy and safety of the study drug compared to placebo for the treatment of subjects with perennial allergic rhinitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | INS37217 Nasal Spray |
Timeline
- Start date
- 2002-12-01
- Primary completion
- 2003-04-01
- Completion
- 2003-04-01
- First posted
- 2005-09-21
- Last updated
- 2016-01-25
Source: ClinicalTrials.gov record NCT00210015. Inclusion in this directory is not an endorsement.